The non-profit Multidisciplinary Association of Psychedelic Studies (MAPS) is leading the development of MDMA and has just reported top-line results from a phase 3 trial of the drug combined with ...
Navy Times on MSN5mon
FDA rejects psychedelic MDMA as treatment for PTSDA handful of therapists in California used MDMA during the 1970s and 1980s - when it was still legal - to facilitate couples ...
"Our advocacy efforts focussed on a limited rescheduling of MDMA and psilocybin as unregistered medicines, whereas MAPS was pursuing registration of MDMA." Citing new research into psychedelic ...
The Multidisciplinary Association for Psychedelic Studies (MAPS) — a 501(c)(3 ... board members — has been a leader in the study of MDMA-assisted therapy. In a phase 3 clinical trial of ...
MAPS Executive Director Rick Doblin has been working to legalize MDMA for PTSD since the 1980's as ... [+] well as other psychedelics for healing and transformation (Photo by John Lamparski/Getty ...
“In determining the efficacy of MDMA for PTSD, MAPS conducted robust research that included two randomized, double-blind, placebo-controlled Phase 3 studies, with the results published in a ...
PharmAla will seek to ship its LaNeo MDMA Clinical Research Materials to Merhavim at the first opportunity, subject to customary regulatory approvals. PharmAla looks forward to additional ...
The non-profit Multidisciplinary Association of Psychedelic Studies (MAPS) is leading the development of MDMA and has just reported top-line results from a phase 3 trial of the drug combined with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback